Neurocognitive Abnormalities in Stimulant Abuse Among High-Risk Women
1 other identifier
observational
334
1 country
1
Brief Summary
Substance use disorders and psychopathy are serious and costly mental health issues. Psychopathy is known to be associated with aberrant moral decision making and there is considerable interest in determining whether substance use disorders lead to impairments in these same cognitive processes. Recent large-scale research initiatives in forensic settings have begun to identify substance abuse and psychopathy-related disruption in the neural mechanisms involved in moral decision-making processes, and associations between these neural networks and future relapse and antisocial behavior. Here the investigators extend prior work (with incarcerated men) to examine these issues among incarcerated women in order to better understand sex differences. This project addresses the overall lack of neurocognitive research in criminal offenders with substance use disorders, thereby focusing on a major public health issue in an underserved and understudied population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2022
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2022
CompletedFirst Submitted
Initial submission to the registry
April 7, 2023
CompletedFirst Posted
Study publicly available on registry
May 6, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 31, 2027
May 8, 2025
May 1, 2025
4.8 years
April 7, 2023
May 5, 2025
Conditions
Outcome Measures
Primary Outcomes (22)
Gray matter volume during MRI scan & stimulant use
Gray matter volume (using relevant MRI analysis platforms - Statistical Parametric Mapping/SPM) correlation with stimulant use (assessed using a modified version of the Addiction Severity Index)
During MRI procedure
White matter integrity during MRI scan & stimulant use
White matter integrity (using relevant MRI analysis platforms - Functional Magnetic Resonance Imaging of the Brain software library (FSL)) correlation with stimulant use (assessed using a modified version of the Addiction Severity Index)
During MRI procedure
Functional brain response during MRI scan & stimulant use during simple linguistic decision task
Functional brain responses (Blood Oxygen Level Dependent/BOLD) (using relevant MRI analysis platforms - SPM, Group Independent Components Analysis Functional Toolbox/GIFT) during Simple Linguistic Decision Task correlation with stimulant use (assessed using a modified version of the Addiction Severity Index)
During MRI procedure
Functional brain response during MRI scan & stimulant use during simple picture decision task
Functional brain responses (Blood Oxygen Level Dependent/BOLD) (using relevant MRI analysis platforms - SPM, Group Independent Components Analysis Functional Toolbox/GIFT) during Simple Picture Decision Task correlation with stimulant use (assessed using a modified version of the Addiction Severity Index)
During MRI procedure
Functional brain response during MRI scan & stimulant use during moral linguistic decision task
Functional brain responses (Blood Oxygen Level Dependent/BOLD) (using relevant MRI analysis platforms - SPM, Group Independent Components Analysis Functional Toolbox/GIFT) during Moral Linguistic Decision Task correlation with stimulant use (assessed using a modified version of the Addiction Severity Index)
During MRI procedure
Functional brain response during MRI scan & stimulant use during moral picture decision task
Functional brain responses (Blood Oxygen Level Dependent/BOLD) (using relevant MRI analysis platforms - SPM, Group Independent Components Analysis Functional Toolbox/GIFT) during Moral Picture Decision Task correlation with stimulant use (assessed using a modified version of the Addiction Severity Index)
During MRI procedure
Functional connectivity during MRI scan & stimulant use during simple linguistic decision task
Functional connectivity (using relevant analysis MRI platforms - GIFT) during Simple Linguistic Decision Task correlation with stimulant use (assessed using a modified version of the Addiction Severity Index)
During MRI procedure
Functional connectivity during MRI scan & stimulant use during simple picture decision task
Functional connectivity (using relevant analysis MRI platforms - GIFT) during Simple Linguistic Decision Task correlation with stimulant use (assessed using a modified version of the Addiction Severity Index)
During MRI procedure
Functional connectivity during MRI scan & stimulant use during moral linguistic decision task
Functional connectivity (using relevant analysis MRI platforms - GIFT) during Moral Linguistic Decision Task correlation with stimulant use (assessed using a modified version of the Addiction Severity Index)
During MRI procedure
Functional connectivity during MRI scan & stimulant use during moral picture decision task
Functional connectivity (using relevant analysis MRI platforms - GIFT) during Moral Picture Decision Task correlation with stimulant use (assessed using a modified version of the Addiction Severity Index)
During MRI procedure
Gray matter volume during MRI scan & psychopathic traits
Gray matter volume (using relevant MRI analysis platforms - Statistical Parametric Mapping/SPM) correlation with psychopathic traits (assessed using the Psychopathy Checklist-Revised)
During MRI procedure
White matter integrity during MRI scan & psychopathic traits
White matter integrity (using relevant MRI analysis platforms - Functional Magnetic Resonance Imaging of the Brain software library (FSL)) correlation with psychopathic traits (assessed using the Psychopathy Checklist-Revised)
During MRI procedure
Functional brain response during MRI scan & psychopathic traits during simple linguistic decision task
Functional brain responses (Blood Oxygen Level Dependent/BOLD) (using relevant MRI analysis platforms - SPM, Group Independent Components Analysis Functional Toolbox/GIFT) during Simple Linguistic Decision Task correlation with psychopathic traits (assessed using the Psychopathy Checklist-Revised)
During MRI procedure
Functional brain response during MRI scan & psychopathic traits during simple picture decision task
Functional brain responses (Blood Oxygen Level Dependent/BOLD) (using relevant MRI analysis platforms - SPM, Group Independent Components Analysis Functional Toolbox/GIFT) during Simple Picture Decision Task correlation with psychopathic traits (assessed using the Psychopathy Checklist-Revised)
During MRI procedure
Functional brain response during MRI scan & psychopathic traits during moral linguistic decision task
Functional brain responses (Blood Oxygen Level Dependent/BOLD) (using relevant MRI analysis platforms - SPM, Group Independent Components Analysis Functional Toolbox/GIFT) during Moral Linguistic Decision Task correlation with psychopathic traits (assessed using the Psychopathy Checklist-Revised)
During MRI procedure
Functional brain response during MRI scan & psychopathic traits during moral picture decision task
Functional brain responses (Blood Oxygen Level Dependent/BOLD) (using relevant MRI analysis platforms - SPM, Group Independent Components Analysis Functional Toolbox/GIFT) during Moral Picture Decision Task correlation with psychopathic traits (assessed using the Psychopathy Checklist-Revised)
During MRI procedure
Functional connectivity during MRI scan & psychopathic traits during simple linguistic decision task
Functional connectivity (using relevant analysis MRI platforms - GIFT) during Simple Linguistic Decision Task correlation with psychopathic traits (assessed using the Psychopathy Checklist-Revised)
During MRI procedure
Functional connectivity during MRI scan & psychopathic traits during simple picture decision task
Functional connectivity (using relevant analysis MRI platforms - GIFT)) during Simple Picture Decision Task correlation with psychopathic traits (assessed using the Psychopathy Checklist-Revised)
During MRI procedure
Functional connectivity during MRI scan & psychopathic traits during moral linguistic decision task
Functional connectivity (using relevant analysis MRI platforms - GIFT) during Moral Linguistic Decision Task correlation with psychopathic traits (assessed using the Psychopathy Checklist-Revised)
During MRI procedure
Functional connectivity during MRI scan & psychopathic traits during moral picture decision task
Functional connectivity (using relevant analysis MRI platforms - GIFT) during Moral Picture Decision Task correlation with psychopathic traits (assessed using the Psychopathy Checklist-Revised)
During MRI procedure
Relapse to/change in stimulant use post-release
Return to stimulant use (assessed using timeline follow back calendar (TLFB)) post-release from incarceration
Every 3 months post release for duration of grant (5 years)
Return to/change in antisocial behavior post-release
Return to antisocial behavior (assessed via self report and/or official records) post-release from incarceration
Every 3 months post release for duration of grant (5 years)
Study Arms (7)
Stimulant Use Severity High
Stimulant Use Severity Medium
Stimulant Use Severity Low
Psychopathic Traits High
Psychopathic Traits Medium
Psychopathic Traits Low
Community (Healthy) Controls
Interventions
Participants will complete a simple and/or moral decision making functional MRI task.
Eligibility Criteria
Incarcerated and non-incarcerated adult women
You may qualify if:
- Biological sex is female
- Intelligence Quotient 70 or higher
- Reading level 5th grade or higher
- Able to speak and understand English
You may not qualify if:
- Uncorrectable auditory or visual deficits
- Currently pregnant
- MRI contraindication
- Central nervous system disease
- Current major medical condition
- Hypertension with complications (e.g., stroke)
- Diabetes with complications
- Lifetime history of psychotic disorder
- Self-report of psychotic disorder (with psychiatric hospitalization) in first degree relative
- Drug use in past three months
- (Healthy controls only):
- History of arrest
- Substance use beyond light alcohol or marijuana use
- Currently taking psychotropic medications
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Mind Research Network
Albuquerque, New Mexico, 87106, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Psychology, Neuroscience and Law, Executive Science Officer
Study Record Dates
First Submitted
April 7, 2023
First Posted
May 6, 2023
Study Start
August 1, 2022
Primary Completion (Estimated)
May 31, 2027
Study Completion (Estimated)
May 31, 2027
Last Updated
May 8, 2025
Record last verified: 2025-05